In Vivo Toxicology Market to Surpass USD 25.90 Billion by 2035; Rising Demand for Drug Safety Assessment and Expanding Biologics Pipeline Driving Market Growth – SNS Insider [Yahoo! Finance]
3 Reasons CRL is Risky and 1 Stock to Buy Instead [Yahoo! Finance]
Locus Cell, Taiwan-Based Cell and Gene Therapy CDMO, Signs MoU with Charles River at APAC Biomanufacturing Leadership Summit [Yahoo! Finance]
Charles River Laboratories International (CRL) Gains on Strong Results and Resilient Drug Outsourcing Demand [Yahoo! Finance]
A Look Back at Drug Development Inputs & Services Stocks' Q4 Earnings: Charles River Laboratories (NYSE:CRL) Vs The Rest Of The Pack [Yahoo! Finance]